GOLDENWELL BIOTECH INC. (GWLL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GWLL Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how GOLDENWELL BIOTECH INC. manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.01
Cash & Short-term Investments0.00
Inventories0.00
Total loans net0.02
Total Current Assets0.02
Other Assets, Noncurrent0.03
Total Assets0.03
Liabilities
Other Liabilities, Current0.10
Deferred Liability and Revenue0.00
Total Current Liabilities0.10
Total Long-term Debt0.00
Other liabilities, Noncurrent0.33
Total Liabilities0.43
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1.30
Retained Earnings / Accumulated Deficit-1.71
Common Stockholder's Equity-0.40
Total Stockholder's Equity-0.40
Liabilities & Stockholder's Equity0.03
4 historic quarters locked

Sign in to unlock the full GOLDENWELL BIOTECH INC. balance sheet history.

About Goldenwell Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: gdwl_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-26-005067

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.